MoonLake Immunotherapeutics (MLTX) Shareholder's Equity (2020 - 2026)
MoonLake Immunotherapeutics (MLTX) Shareholder's Equity (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 502.95 Mn |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - | 254.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254.02 Mn |
| Dec 31, 2025 | 304.48 Mn |
| Sep 30, 2025 | 288.91 Mn |
| Jun 30, 2025 | 357.94 Mn |
| Mar 31, 2025 | 412.58 Mn |
| Dec 31, 2024 | 446.83 Mn |
| Sep 30, 2024 | 495.50 Mn |
| Jun 30, 2024 | 530.03 Mn |
| Mar 31, 2024 | 552.39 Mn |
| Dec 31, 2023 | 513.49 Mn |
| Sep 30, 2023 | 489.64 Mn |
| Jun 30, 2023 | 499.11 Mn |
| Mar 31, 2023 | 59.11 Mn |
| Dec 31, 2022 | 68.77 Mn |
| Sep 30, 2022 | 82.57 Mn |
| Jun 30, 2022 | 94.56 Mn |
| Mar 31, 2022 | -25.27 Mn |
| Dec 31, 2021 | -11.65 Mn |
| Sep 30, 2021 | -3.10 Mn |
| Jun 30, 2021 | 828,658.00 |